Lower-cost transactional solutions with strategic resourcing and innovative technologies.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Offering solutions that combine in-house expertise and proprietary innovative technology.
Experience in cardiovascular trials supported by a global team of experts.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Digital solutions that increase efficiency in clinical trials by driving site performance.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
The traditional clinical development model needs to change.
Understand and successfully address the complexities of adaptive trial design.
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
6 - 7 January, 2018Meet ICON to learn about the latest developments in life sciences and pharma
7 - 9 February, 2018Learn about the future of immuno-oncology and emerging challenges in drug development
24/7On-demand webinar replays on a range of issues
From a small team of 5 people in 1990, ICON now employs over 13,100 professionals in 38 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.